Investors.coherus.com

  1. Home
  2. Investors.coherus.com

Coherus BioSciences, Inc. Overview

WebCoherus is a commercial-stage biopharmaceutical company focused on researching, developing, and commercializing innovative immunotherapies to treat …

Actived: Just Now

URL: https://investors.coherus.com/

Coherus BioSciences, Inc. 42nd Annual J.P. Morgan Healthcare …

WebSupporting Materials. Coherus JP Morgan Presentation – January 2024. Events for Coherus BioSciences, Inc., a commercial-stage biopharmacetucial company …

Category:  Health Go Health

Coherus BioSciences, Inc. 41st Annual J.P. Morgan Healthcare …

Web41st Annual J.P. Morgan Healthcare Conference. Jan 10, 2023 8:15 AM PST. Click here for Webcast. Events for Coherus BioSciences, Inc., a commercial-stage …

Category:  Health Go Health

Coherus BioSciences, Inc. Coherus BioSciences Management to …

WebREDWOOD CITY, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus,” Nasdaq: CHRS), today announced that senior management will present at …

Category:  Health Go Health

Junshi Biosciences and Coherus BioSciences Announce Initiation of

Web- BLA submitted with FDA’s breakthrough therapy designation – SHANGHAI, China, and REDWOOD CITY, Calif., March 03, 2021 (GLOBE NEWSWIRE) -- Shanghai …

Category:  Health Go Health

Coherus BioSciences, Inc. Coherus Announces U.S. FDA Approval …

WebYUSIMRY is indicated for plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, Crohn’s disease, and …

Category:  Health Go Health

Coherus BioSciences, Inc. Coherus BioSciences to Receive $50 …

WebREDWOOD CITY, Calif., Feb. 02, 2021 (GLOBE NEWSWIRE) -- A day after announcing their new immuno-oncology collaboration, Coherus BioSciences, Inc. (Nasdaq: CHRS) …

Category:  Health Go Health

Coherus BioSciences, Inc. Press Releases

WebCoherus BioSciences Announces New Employment Inducement Grants. Feb 23, 2024. 1. 2. ›. ». Press releases for Coherus BioSciences, Inc., a commercial-stage …

Category:  Health Go Health

Coherus BioSciences, Inc. Coherus BioSciences Reports Third …

WebNon-GAAP net loss for the third quarter of 2021 was $26.6 million, or $ (0.34) per share on a diluted basis, compared to non-GAAP net income of $39.7 million, …

Category:  Health Go Health

Coherus BioSciences, Inc. Coherus BioSciences Appoints Dr.

Web– Recognized biopharma commercialization and market access leader to support Coherus’ strategic vision and multiple product launches – REDWOOD CITY, Calif., July 20, 2023 …

Category:  Health Go Health

Coherus BioSciences, Inc. Coherus Announces U.S. Launch of …

Web–Innovative design enables five-minute pegfilgrastim-cbqv delivery time – – Unique, automatic, retractable needle mechanism engineered to maximize safety and …

Category:  Health Go Health

Coherus BioSciences, Inc. UBS Global Healthcare Conference

WebUBS Global Healthcare Conference. May 23, 2023 1:1s for conference attendees only. Follow Us

Category:  Health Go Health

Coherus BioSciences, Inc. Coherus Acquires Commercial Rights …

WebCompany’s First Ophthalmology Franchise Launch Pulled Forward by Two Years. REDWOOD CITY, Calif., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Coherus …

Category:  Health Go Health

Coherus BioSciences, Inc. Coherus and Junshi Biosciences Share …

Web- FDA has been unable to travel to China to conduct the required site inspection resulting in delayed action on the BLA - - Coherus and Junshi Biosciences are …

Category:  Health Go Health

Coherus BioSciences, Inc. Coherus BioSciences Appoints Alan …

WebREDWOOD CITY, Calif., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced the appointments of …

Category:  Health Go Health

Coherus BioSciences, Inc. Coherus BioSciences Mourns the …

WebREDWOOD CITY, Calif., Oct. 11, 2021 (GLOBE NEWSWIRE) -- It is with profound sadness that Coherus BioSciences, Inc. (Nasdaq: CHRS) announces the unexpected passing of …

Category:  Health Go Health

Coherus BioSciences, Inc. Coherus BioSciences Mourns the

WebREDWOOD CITY, Calif., Sept. 29, 2021 (GLOBE NEWSWIRE) -- It is with profound sadness that Coherus BioSciences, Inc. (Nasdaq: CHRS) announces the passing of …

Category:  Health Go Health

Coherus BioSciences, Inc. Coherus Launches YUSIMRY™, a

Web–$995 per carton (two 40 mg/0.8 mL autoinjectors) represents a discount of more than 85% compared to Humira® – – YUSIMRY™ meets high unmet need by …

Category:  Health Go Health

Coherus BioSciences, Inc. Coherus BioSciences Announces …

WebREDWOOD CITY, Calif., Nov. 30, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that the company has executed a 340B prime …

Category:  Health Go Health

Top Categories

 › Appendicitis

 › Headaches

 › Gout

 › Women's Health

 › Thyroid

 › Sleep

 › Skin

 › Sexual Health

 › Senior Health

 › Pregnancy

 › Oral Health

 › Neurology

 › Migraine

 › Mental Health

 › Men's Health

 › Menopause

 › Medications

 › Lung Conditions

 › Infectious Disease

 › HIV/AIDS

Popular Searched

 › Mental health america of fred

 › Belfast health and social care waiting list

 › Va augusta health care department

 › Aurora behavioral health fund du lac

 › Queensland health sleep disorder management

 › Social health insurance payment methods

 › South african health declaration form

 › Superior health plan centene

 › Dg health office dehradun

 › Queensland health sleep center

Recently Searched

 › Ohio health colon cancer center

 › Health insurance after 65 canada

 › Black health matters book

 › Ohio health employee handbook

 › 5 rivers health center dayton ohio

 › Dr beasley health concepts

 › Healthy parks healthy people initiative

 › Mail cope health scholars

 › Government insurance for health care workers

 › Highmark health appeals and complaints